The pharmaceutical industry is regularly chastised for failing to do enough to ensure that people in low and middle-income countries have access to its medicines. Yet the real picture is actually more nuanced, according to a newly released report that finds some – but not all – drug makers are making headway. Some companies, for […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AXUMIN (fluciclovine f-18) Blue Earth Patent number: 5,808,146 Expiration Date: Nov 9, 2016 GADAVIST (gadobutrol) Bayer Hlthcare Patent number: 5,980,864 Expiration Date: Nov 9, 2016 BROVANA […]
To date, the Patent Trial and Appeal Board has reached a final decision in eight instituted inter partes review (IPR) challenges, including seven IPRs filed by the Coalition for Affordable Drugs and one IPR filed by Erich Spangenberg and me personally on a not-for-profit basis. The outcomes were favorable in seven of the eight IPRs. […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AXUMIN (fluciclovine f-18) Blue Earth Patent number: 5,808,146 Expiration Date: Nov 9, 2016 GADAVIST (gadobutrol) Bayer Hlthcare Patent number: 5,980,864 Expiration Date: Nov 9, 2016 BROVANA […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. NEXIUM (esomeprazole magnesium) Astrazeneca Pharms Patent number: 5,900,424 Expiration Date: Nov 4, 2016 VIMOVO (esomeprazole magnesium; naproxen) Horizon Pharma Usa Patent number: 5,900,424 Expiration Date: Nov […]
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is highlighted by a significant milestone for our shortest person, who turns another page in the book of life. And so, we will […]
This is a guest post from DrugPatentWatch. Do you have a response to DrugPatentWatch’s post? Respond in the comments section below. If domestic pharmaceutical distribution is complex, international distribution is considerably more complicated International growth markets for pharmaceuticals represent enormous opportunities, but they also bring their own unique challenges, including infrastructure, fragmented distribution, and a patchwork […]
By Devon Herrick / NCPA House Minority Leader Nancy Pelosi actually agrees on one thing with Speaker Paul Ryan and Senate Majority Leader Mitch McConnell. All three support the 21st Century Cures Act. There is no word about whether Pelosi has actually read the bill. Maybe she wants to pass it to find out what’s […]
A new Cuban lung cancer vaccine is coming to the United States, the Roswell Park Cancer Center announced Wednesday. The U.S. Food and Drug Administration approved a clinical trial for the vaccination at the center in Buffalo, New York, marking the first time a Cuban-made therapy will be available for patients in the U.S. The […]
DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them Click the patents below for more details, or visit DrugPatentWatch.com for more options. AZOR (amlodipine besylate; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration Date: Oct 25, 2016 BENICAR HCT (hydrochlorothiazide; olmesartan medoxomil) Daiichi Sankyo Patent number: 5,616,599 Expiration […]